Reliq Health Technologies, Inc. Announces Four New US Contracts, Go-Live with Data Soft Logic
July 19 2022 - 3:01AM
Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or
WKN:A2AJTB) (“
Reliq” or the
“
Company”), a rapidly growing global healthcare
technology company that develops innovative Virtual Care solutions
for the multi-billion dollar Healthcare market, today announced
that it has signed new contracts with four physician practices in
California and Texas to add over 5,000 new patients to its
platform. The Company is also pleased to announce that it has gone
live with the first client through its partnership agreement with
Data Soft Logic. Onboarding with Data Soft Logic is expected to
ramp up over the remainder of 2022, adding over 50,000 patients per
year to Reliq’s iUGO Care platform in 2023 and beyond.
“We are pleased to be adding four new physician
practices in California and Texas,” said Dr. Lisa Crossley, CEO at
Reliq Health Technologies, Inc. “Together these clients are
expected to add over 5,000 patients to our platform in the next
nine months at an average revenue of $50 per patient per month at
75% gross margin. Onboarding with these clients is expected to
begin next month.”
“We are also very excited to have gone live with
our first client through our partnership with Data Soft Logic.
Onboarding has already begun with the client. Data Soft Logic is a
provider of cloud-based home health and hospice care solutions that
include point of care, billing, scheduling, accounting and human
resources applications. Their solutions are currently used by over
600 home health and hospice care agencies across the United States.
Data Soft Logic’s home health and hospice clients work with over
1,000 primary care physicians who provide care to over 500,000
Medicare and Medicaid patients. As previously disclosed, the
Company expects to add over 50,000 patients per year to the
platform beginning in 2023 through the partnership with Data Soft
Logic, at an average revenue of $60 per patient per month (at 75%
gross margin). Reliq remains on track to have over 100,000 patients
on our iUGO Care platform by December 31, 2022.”
About Data Soft LogicData Soft
Logic Corporation is a cloud-based home health care and Hospice
solution offering a suite of applications including Point of Care,
Symptom Management, Billing, Scheduling, Accounting and Human
Resources. Data Soft Logic software is powerful and meaningful with
simplicity of use for superior connected care at point of delivery.
We are proud to have partnered with home health, hospice, and
therapy agencies for over 10 years. Learn more at
www.datasoftlogic.com.
Reliq HealthReliq Health
Technologies is a rapidly growing global healthcare technology
company that specializes in developing innovative Virtual Care
solutions for the multi-billion dollar Healthcare market. Reliq’s
powerful iUGO Care platform supports care coordination and
community-based virtual healthcare. iUGO Care allows complex
patients to receive high quality care at home, improving health
outcomes, enhancing quality of life for patients and families and
reducing the cost of care delivery. iUGO Care provides real-time
access to remote patient monitoring data, allowing for timely
interventions by the care team to prevent costly hospital
readmissions and ER visits. Reliq Health Technologies trades on the
TSX Venture under the symbol RHT, on the OTC as RQHTF and on the
Frankfurt Stock Exchange under the WKN: A2AJTB.
ON BEHALF OF THE BOARD“Dr. Lisa Crossley”CEO and Director
For further information please contact:
Company ContactInvestor Relations at
ir@reliqhealth.com
US Investor Relations ContactInvestor
RelationsLytham Partners, LLCBen ShamsianNew York |
Phoenix646-829-9701shamsian@lythampartners.com
Neither the TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward
Looking InformationCertain statements in this press
release constitute forward-looking statements, within the meaning
of applicable securities laws. All statements that are not
historical facts, including without limitation, statements
regarding future estimates, plans, programs, forecasts,
projections, objectives, assumptions, expectations or beliefs of
future performance, are "forward-looking statements".
We caution you that such "forward-looking
statements" involve known and unknown risks and uncertainties that
could cause actual and future events to differ materially from
those anticipated in such statements.
Forward-looking statements include, but are not
limited to, statements with respect to commercial operations,
including technology development, anticipated revenues, projected
size of market, and other information that is based on forecasts of
future results, estimates of amounts not yet determinable and
assumptions of management.
Reliq Health Technologies Inc. (the
"Company") does not intend and does not assume any
obligation, to update these forward-looking statements except as
required by law. These forward-looking statements involve risks and
uncertainties relating to, among other things, technology
development and marketing activities, the Company's historical
experience with technology development, uninsured risks. Actual
results may differ materially from those expressed or implied by
such forward-looking statements.
SOURCE: Reliq Health Technologies Inc.
Reliq Health Technologies (TSXV:RHT)
Historical Stock Chart
From Jun 2024 to Jul 2024
Reliq Health Technologies (TSXV:RHT)
Historical Stock Chart
From Jul 2023 to Jul 2024